Incisional Infiltration of Liposomal Bupivacaine in Geriatric Hip Fracture Surgery: A Randomized Parallel-Group Trial.
Yu, Xiang X; Yuan, Yi Y; Zhao, Song S; et al.
In a single-center, randomized, participant- and assessor-blinded trial of 76 older adults (median age 77) undergoing hemiarthroplasty or total hip arthroplasty for hip fracture, investigators compared local incisional infiltration of liposomal bupivacaine (LB) versus no local infiltration as an adjunct to standardized multimodal analgesia. The prespecified primary outcome—resting VAS pain at 48 hours—did not differ between groups, but several secondary outcomes favored LB (lower resting pain at 24 hours, reduced activity pain at 8–48 hours, fewer oral rescue opioid administrations, and improved postoperative sleep duration/quality), while ambulation and length of stay were similar. The authors conclude that LB did not improve the primary endpoint and do not support routine clinical use pending further research.